Business Description
Molecure SA
ISIN : PLONCTH00011
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 7.91 | |||||
Equity-to-Asset | 0.87 | |||||
Debt-to-Equity | 0.07 | |||||
Debt-to-EBITDA | -0.38 | |||||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Book Growth Rate | -4.6 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 40.97 | |||||
9-Day RSI | 45.17 | |||||
14-Day RSI | 45.08 | |||||
6-1 Month Momentum % | -22.55 | |||||
12-1 Month Momentum % | -26.83 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.79 | |||||
Quick Ratio | 5.79 | |||||
Cash Ratio | 5.56 | |||||
Days Payable | 1103.13 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -7.2 | |||||
Shareholder Yield % | -0.11 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -14.64 | |||||
ROA % | -13.52 | |||||
ROIC % | -27.5 | |||||
ROC (Joel Greenblatt) % | -168.17 | |||||
ROCE % | -14.06 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shiller PE Ratio | 87.77 | |||||
PB Ratio | 2.67 | |||||
Price-to-Tangible-Book | 5.06 | |||||
EV-to-EBIT | -10.74 | |||||
EV-to-EBITDA | -11.88 | |||||
EV-to-FCF | -3.82 | |||||
Price-to-Net-Current-Asset-Value | 6.32 | |||||
Price-to-Net-Cash | 6.66 | |||||
Earnings Yield (Greenblatt) % | -9.31 | |||||
FCF Yield % | -21.42 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Molecure SA Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil zł) | |||
EPS (TTM) (zł) | -1.17 | ||
Beta | 1.87 | ||
Volatility % | 34.88 | ||
14-Day RSI | 45.08 | ||
14-Day ATR (zł) | 0.625816 | ||
20-Day SMA (zł) | 15.045 | ||
12-1 Month Momentum % | -26.83 | ||
52-Week Range (zł) | 14.14 - 25.5 | ||
Shares Outstanding (Mil) | 16.84 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Molecure SA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Molecure SA Stock Events
Event | Date | Price(zł) | ||
---|---|---|---|---|
No Event Data |
Molecure SA Frequently Asked Questions
What is Molecure SA(WAR:MOC)'s stock price today?
When is next earnings date of Molecure SA(WAR:MOC)?
Does Molecure SA(WAR:MOC) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |